{
    "clinical_study": {
        "@rank": "133021", 
        "brief_summary": {
            "textblock": "Kidney diseases related to the immune system include, nephrotic syndrome,\n      glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with\n      connective tissue disorders.\n\n      This study will allow researchers to admit and follow patients suffering from autoimmune\n      diseases of the kidney.  It will attempt to provide information about the causes and\n      specific abnormalities associated with autoimmune kidney disease.\n\n      Patients with kidney disease as a result of their immune system, and patients with diseases\n      of the immune system who may later develop kidney disease, will be potential subjects for\n      this study.\n\n      Patients will undergo a history and physical examination, and standard laboratory test to\n      more closely understand the causes, signs, symptoms, and responses to medication of these\n      diseases.  Based on these evaluations the patients may qualify as candidates for other\n      experimental studies.  At any time these patients may be asked to submit blood or urine\n      samples for further research."
        }, 
        "brief_title": "Immune System Related Kidney Disease", 
        "condition": [
            "Glomerulonephritis", 
            "Lupus Nephritis", 
            "Membranous Glomerulonephritis", 
            "Nephritis", 
            "Nephrotic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glomerulonephritis", 
                "Glomerulonephritis, Membranous", 
                "Kidney Diseases", 
                "Lupus Nephritis", 
                "Nephritis", 
                "Nephrotic Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with known or suspected immunologically-mediated kidney diseases, including but not\n      limited to, nephritic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis,\n      and nephritis associated with other systemic or connective tissue disorders, will be\n      evaluated at the Clinical Center.  Patients who have immunologically-mediated diseases with\n      potential for kidney disease will be evaluated as well.  Studies will include\n      characterization of the clinical and laboratory features of these disorders, studies of\n      natural history and complications, evaluation of responses to standard treatment, and\n      determination of the patients' eligibility to enter other experimental diagnostic or\n      therapeutic protocols.  Patients may be asked to contribute blood and/or urine samples for\n      immunological research studies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Immunologically-mediated renal diseases, proven or suspected.\n\n        Immunologically-mediated diseases with potential for kidney disease.\n\n        Willingness of the patient or guardian to give informed consent.\n\n        EXCLUSION CRITERIA:\n\n        Concomitant medical problems which would confound the interpretation of studies of the\n        immunologic kidney disorder.\n\n        Concomitant medical, surgical or other conditions for which inadequate facilities or funds\n        are available to support their care at the NIH."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "99999999", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001979", 
            "org_study_id": "920156", 
            "secondary_id": "92-DK-0156"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glomerulonephritis", 
            "Nephropathy", 
            "Lupus", 
            "Nephritis", 
            "Nephrotic Syndrome"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1992-DK-0156.html"
        }, 
        "location": {
            "contact": {
                "email": "prpl@mail.cc.nih.gov", 
                "last_name": "For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)", 
                "phone": "800-411-1222", 
                "phone_ext": "TTY8664111010"
            }, 
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Studies of Immunologically-Mediated Kidney Diseases", 
        "overall_contact": {
            "email": "howarda@intra.niddk.nih.gov", 
            "last_name": "Howard A Austin, M.D.", 
            "phone": "(301) 435-5055"
        }, 
        "overall_official": {
            "affiliation": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
            "last_name": "Howard A Austin, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "1546869", 
                "citation": "Austin HA 3rd, Antonovych TT, MacKay K, Boumpas DT, Balow JE. NIH conference. Membranous nephropathy. Ann Intern Med. 1992 Apr 15;116(8):672-82. Review."
            }, 
            {
                "PMID": "3511372", 
                "citation": "Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986 Mar 6;314(10):614-9."
            }, 
            {
                "PMID": "3789582", 
                "citation": "Balow JE, Austin HA 3rd, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH. NIH conference. Lupus nephritis. Ann Intern Med. 1987 Jan;106(1):79-94."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001979"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1992", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}